Cervical lymph node metastasis and papillary thyroid carcinoma: Does the compartment involved affect survival? Experience from the SEER database

Journal of Surgical Oncology

Volumn 106, Issue 4, 2012, Pages 357-362

  Smith, Valerie A ^a   Sessions, Roy B ^a   Lentsch, Eric J ^a  

^a MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

Author keywords

cervical lymph nodes; papillary thyroid carcinoma; SEER database

Indexed keywords

ADULT; AGED; ARTICLE; CANCER MORTALITY; CANCER SIZE; CANCER SURVIVAL; CERVICAL LYMPH NODE; DISEASE SPECIFIC SURVIVAL; DISTANT METASTASIS; FEMALE; HUMAN; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; PAPILLARY CARCINOMA; PRIORITY JOURNAL; RISK ASSESSMENT; THYROID CARCINOMA; THYROIDECTOMY;

ADULT; AGE FACTORS; AGED; FEMALE; HUMANS; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; NEOPLASM STAGING; PROPORTIONAL HAZARDS MODELS; SEER PROGRAM; THYROID NEOPLASMS; THYROIDECTOMY;

EID: 84865112320     PISSN: 00224790     EISSN: 10969098     Source Type: Journal    
DOI: 10.1002/jso.23090     Document Type: Article

References (31)

1. Davies L, Welch HG,: Increasing incidence of thyroid cancer in the United States, 1973-2002. JAMA 2006; 295: 2164-2167.
2. Sippel RS, Chen H,: Controversies in the surgical management of newly diagnosed and recurrent/residual thyroid cancer. Thyroid 2009; 19: 1373-1380.
3. Mazzaferri EL, Jhiang SM,: Long-term impact of initial surgical and medical therapy on papillary and follicular thyroid cancer. Am J Med 1994; 97: 418-428. (Pubitemid 24345593)
4. Hughes CJ, Shaha AR, Shah JP, et al.: Impact of lymph node metastasis in differentiated carcinoma of the thyroid: A matched-pair analysis. Head Neck 1996; 18: 127-132. (Pubitemid 26075352)
5. Lee YS, Lim SY, Lee JC, et al.: Clinical implication of the number of central lymph nodes metastasis in papillary thyroid carcinoma: Preliminary report. World J Surg 2010; 34: 2558-2563.
6. Surgitani I, Kasai N, Fujimoto Y, et al.: A novel classification system for patients with PTC: Addition of the new variables of large (3 cm or greater) nodal metastases and reclassification during the follow-up period. Surgery 2004; 135: 139-148. (Pubitemid 38130764)
7. Ito Y, Fukushima M, Tomoda C, et al.: Prognosis of patients with papillary thyroid carcinoma having clinically apparent metastasis to the lateral compartment. Endocr J 2009; 56: 759-766.
8. SEER Brochure. National Cancer Institute. NIH Publication No. 05-4772. September 2005. http://www.seer.cancer.gov/about/SEER-brochure.pdf
9. Edge SB, Byrd DR, Compton CC, (editors), et al.: AJCC cancer staging manual, 7th edition. New York, NY: Springer; 2010. pp. 87-96.
10. Cooper DS, Doherty GM, Haugen BR, et al.: Revised American Thyroid Association management guidelines for patients with thyroid nodules and differentiated thyroid cancer. Thyroid 2009; 19: 1167-1214.
11. National Comprehensive Cancer Network (NCCN) Clinical Practice Guidelines in Oncology (NCCN Guidelines). http://www.nccn.org (Accessed on April 21, 2011).
12. Carling T, Lond WD III, Udelsman R,: Controversy surrounding the role for routine central lymph node dissection for differentiated thyroid cancer. Curr Opin Oncol 2010; 22: 30-34.
13. Kupferman ME, Patterson M, Mandel SJ, et al.: Patterns of lateral neck metastasis in papillary thyroid carcinoma. Arch Otolaryngol Head Neck Surg 2004; 130: 857-860. (Pubitemid 38915973)
14. Hay ID, Grant CS, Taylor WF, et al.: Ipsilateral lobectomy versus bilateral lobar resection in papillary thyroid carcinoma: A retrospective analysis of survival outcome using a novel prognostic scoring system. Surgery 1987; 102: 1088-1095. (Pubitemid 18010757)
15. Cady B, Rosai R,: An expanded view of risk group definition in differentiated thyroid carcinoma. Surgery 1988; 104: 947-953. (Pubitemid 19011971)
16. Hay ID, Bergstrahl EJ, Goellner JR, et al.: Predicting outcomes in papillary thyroid carcinoma: Development of a reliable prognostic scoring system in a cohort of 1779 patients surgically treated at one institution during 1940 through 1989. Surgery 1993; 114: 1050-1058. (Pubitemid 24004722)
17. Roh JL, Kim JM, Park CI,: Lateral cervical lymph node metastases from papillary thyroid carcinoma: Pattern of nodal metastases and optimal strategy for neck dissection. Ann Surg Oncol 2008; 15: 1177-1182.
18. Yüce A, Ãaflà S, Bayram A, et al.: Regional metastatic pattern of papillary thyroid carcinoma. Eur Arch Otorhinolaryngol 2010; 267: 437-441.
19. Lang B, Lo CY, Chan WF, et al.: Restaging of differentiated thyroid carcinoma by the sixth edition AJCC/UICC TNM staging system: Stage migration and predictability. Ann Surg Oncol 2007; 14: 1551-1559. (Pubitemid 46790984)
20. Wada N, Masudo K, Nakayama H, et al.: Recommendation for subclass evaluation of TNM stage IVa papillary thyroid carcinomas: T4aN1b patients are at risk for recurrence and survival. Ann Surg Oncol 2008; 15: 1511-1517.
21. Ito Y, Miyauchi A, Jikuzono T, et al.: Risk factors contributing to a poor prognosis of papillary thyroid carcinoma: Validity of UICC/AJCC TNM classification and stage grouping. World J Surg 2007; 31: 83848.
22. Beasley NJ, Lee J, Eski S, et al.: Impact of nodal metastases on prognosis in patients with well-differentiated thyroid cancer. Arch Otolaryngol Head Neck Surg 2002; 128: 825-828. (Pubitemid 34755316)
23. Iyer NG, Kumar A, Nixon IJ, et al.: Incidence and significance of Delphian node metastasis in papillary thyroid cancer. Ann Surg 2011; 253: 988-991.
24. Roh JL, Kim JM, Park CI,: Central lymph node metastasis of unilateral papillary thyroid carcinoma: Patterns and factors predictive of nodal metastasis, morbidity, and recurrence. Ann Surg Oncol 2011; 18: 2245-2250.
25. Moo TA, Umunna B, Kato M, et al.: Ipsilateral versus bilateral central neck lymph node dissection in papillary thyroid carcinoma. Ann Surg 2009; 250: 403-408.
26. Lim YS, Lee JC, Lee YS, et al.: Lateral cervical lymph node metastases from papillary thyroid carcinoma: Predictive factors of nodal metastasis. Surgery 2011; 150: 11621.
27. Salter KD, Andersen PE, Cohen JI, et al.: Central nodal metastases in papillary thyroid carcinoma based on tumor histologic type and focality. Arch Otolaryngol Head Neck Surg 2010; 136: 692-696.
28. Pisanu A, Reccia I, Nardello O, et al.: Risk factors for nodal metastasis and recurrence among patients with papillary thyroid microcarcinoma: Differences in clinical relevance between nonincidental and incidental tumors. World J Surg 2009; 33: 460-468.
29. Mercante G, Frasoldati A, Pedroni C, et al.: Prognostic factors affecting neck lymph node recurrence and distant metastasis in papillary microcarcinoma of the thyroid: Results of a study in 445 patients. Thyroid 2009; 19: 707-716.
30. Byar D, Green S, Dor P, et al.: A prognostic index for thyroid carcinoma: A study of the EORTC Thyroid Cancer Cooperative Group. Eur J Cancer 1979; 15: 472-479.
31. Noguchi S, Murakami N, Kawamoto H,: Classification of papillary cancer of the thyroid based on prognosis. World J Surg 1994; 18: 552-558. (Pubitemid 24273856)